Average Co-Inventor Count = 3.76
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (27 from 2,076 patents)
2. Ortho-mcneil Pharmaceutical Corp. (6 from 363 patents)
3. Other (1 from 832,680 patents)
34 patents:
1. 11230526 - Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors
2. 10988433 - Cyclohexyl GPR40 agonists for the treatment of type II diabetes
3. 9434688 - Indole derivatives as selective androgen receptor modulators (SARMS)
4. 9120830 - 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
5. 9062048 - Cyclohexyl-azetidinyl antagonists of CCR2
6. 8921559 - 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2
7. 8802865 - 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
8. 8765782 - Indole derivatives as selective androgen receptor modulators (SARMS)
9. 8586616 - Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
10. 8575206 - 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
11. 8518969 - Cyclohexyl-azetidinyl antagonists of CCR2
12. 8436023 - Cyclohexyl-azetidinyl antagonists of CCR2
13. 8394971 - Indole derivatives as selective androgen receptor modulators (SARMS)
14. 8269015 - 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of CCR2
15. 7968580 - Imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)